Formulation and evaluation of ethosomes for transdermal delivery of Lamivudine

AAPS PharmSciTech

Volumn 8, Issue 4, 2007, Pages

  Jain, Subheet ^a   Tiwary, Ashok K ^a   Sapra, Bharti ^a   Jain, Narendra K ^b  

^a PUNJABI UNIVERSITY   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

Cell line study; Ethosomes; Fluorescence microscopy; Scanning electron microscopy; Skin; Transmission electron microscopy

Indexed keywords

DRUG VEHICLE; ETHOSOME; LAMIVUDINE; LIPOSOME; UNCLASSIFIED DRUG; ALCOHOL; LIPID; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG STABILITY; DRUG TRANSPORT; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LYMPHOID CELL LINE; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; SKIN PERMEABILITY; SKIN STRUCTURE; TOXICITY TESTING; TRANSMISSION ELECTRON MICROSCOPY; TRANSPORT VESICLE; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; DIFFUSION CHAMBER; DRUG EFFECT; ELASTICITY; IC 50; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PARTICLE SIZE; PERMEABILITY; PHARMACEUTICS; SKIN; SKIN ABSORPTION; SPRAGUE DAWLEY RAT; TIME; ULTRASTRUCTURE;

ADMINISTRATION, CUTANEOUS; ANIMALS; CELL LINE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DIFFUSION CHAMBERS, CULTURE; DRUG COMPOUNDING; DRUG STABILITY; ELASTICITY; ETHANOL; INHIBITORY CONCENTRATION 50; LAMIVUDINE; LIPIDS; LIPOSOMES; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; PARTICLE SIZE; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE INHIBITORS; SKIN; SKIN ABSORPTION; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 38049138955     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt0804111     Document Type: Article

References (25)

1. Jarvis B, Faulds D. Lamivudine: a review of its therapeutic potential in chronic hepatitis B. Drugs. 1999;58:101-141.
2. Dutta T, Jain NK. Targeting potential and anti-HIV activity of lamivudine-loaded mannosylated poly(propyleneimine) dendrimer. Biochim Biophys Acta. 2007;1770:681-686.
3. Schreier H, Bouwstra J. Liposomes and niosomes as a drug carriers: dermal and transdermal drug delivery. J Control Release. 1994;30:1-15.
4. Cevc G, Blume G, Schatzlein A, Gebauer D, Paul A. The skin: a pathway for the systemic treatment with patches and lipid based agent carriers. Adv Drug Deliv Rev. 1996;18:349-378.
5. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000;65:403-418.
6. Touitou E, inventor. Composition of applying active substance to or through the skin. US patent 5 540 934. July 30, 1996.
7. Touitou E, inventor. Composition of applying active substance to or through the skin. US patent 5 716 638. October 2, 1998.
8. Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F. Intracellular delivery mediated by an ethosomal carrier. Biomaterials. 2001;22:3053-3059.
9. Jain S, Umamaheshwari RB, Bhadra D, Jain NK. Ethosomes: a novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent. Ind J Pharma Sci. 2004;66:72-81.
10. Bangham AD, Standish MM, Watkins JC. The action of steroids and streptolysin S on the permeability of phospholipid structures to cations. J Mol Biol. 1965;13:253-259.
11. Lopez-Pinto JM, Gonzalez-Rodriguez ML, Robasco AM. Effect of cholesterol and ethanol on dermal delivery of DPPC liposome. Int J Pharm. 2005;298:1-12.
12. Jain S, Jain P, Jain NK. Transfersomes: a novel vesicular carrier for enhanced transdermal delivery: development, characterization and performance evaluation. Drug Dev Ind Pharm. 2003;29:1013-1026.
13. Jain S, Jain N, Bhadra D, Tiwary AK, Jain NK. Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization and performance evaluation. Curr Drug Deliv. 2005;2:223-233.
14. Bedoya LM, Sanchez-Palomino S, Abad MJ, Bermejo P, Alcami J. Anti-HIV activity of medicinal plant extracts. J Ethnopharmacol. 2001;77:113-116.
15. Dusserre N, Lessard C, Paquette N, et al. Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics. AIDS. 1995;9: 833-841.
16. Uslu B, Ozkan SA. Determination of lamivudine and zidovudine in binary mixtures using first derivative spectrophotometric, first derivative of the ratio-spectra and high performance liquid chromatography-UV methods. Anal Chim Acta. 2002;466:175-185.
17. Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release. 2005;106:99-110.
18. Lasic D, Weiner N, Riaz M, Martin F. Liposomes. In: Lieberman A, Rieger M, Banker G, eds. Pharmaceutical Dosage Forms: Disperse Systems. vol. 3. New York, NY: Marcel Dekker, 1998;43-86.
19. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HC1: ethosomes Vs liposomes. Biomaterials. 2000;21:1879-1885.
20. Van den Bergh BAI, Swartzendruber DC, Bos-Van der Geest A, et al. Development of an optimal protocol for the ultrastructural examination of skin by transmission electron microscopy. J Microscopy. 1997;187: 125-133.
21. Kim YH, Ghanem AH, Mahmoud H, Higuchi WI. Short chain alkanols as transport enhancers for lipophilic and polar/ionic permeants in hairless mouse skin: mechanism(s) of action. Int J Pharm. 1992;80:17-31.
22. Krishnaiah YSR, Bhaskar P, Satyanarayana V. Penetration-enhancing effect of ethanol water solvent system and ethanolic solution of carvone on transdermal permeability of nimodipine from HPMC gel across rat abdominal skin. Pharm Dev Technol. 2004;9:63-74.
23. Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membrane from an ethosomal carrier. J Control Release. 2004;187:1-15.
24. Oussoren C, Magnani M, Fraternale A, et al. Liposomes as carrier of the antiviral agent dideoxycytidine-5′-triphosphate. Int J Pharm. 1999;180:261-270.
25. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implication for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223-261.